Company intelligence / Profile preview

Phylos Bioscience

Portland, Oregon, United Statesphylos.bio ↗

Ownership: Private
Development stage: Other

Overview

Phylos Bioscience has commercialized phenotypically stable, fully-feminized F1 hybrid cannabis seeds that deliver high yield and quality. The company also offers genomic testing services and has published foundational data on the cannabis genome. It partners with breeders to license unique genetics and collaborates with Illumina for advanced genotyping arrays. Its research includes rare cannabinoid development (e.g., THCV) and sustainability initiatives in cultivation practices.

Modalities: Plant breedingGenomic selectionMarker-assisted selection
Industry: Agriculture & AgTech

Partnerships

Illumina (for genotyping array development)

Beyond the preview

Go deeper on Phylos Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phylos Bioscience.

Explore the full profile